Epidemiology and pharmacogenetics
11 – 20 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
- Contribution to journal › Article
-
Mark
Germline copy number variants and endometrial cancer risk
- Contribution to journal › Article
-
Mark
Genetic drivers and cellular selection of female mosaic X chromosome loss
- Contribution to journal › Article
-
Mark
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
- Contribution to journal › Article
- 2023
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
- Contribution to journal › Article
-
Mark
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
- Contribution to journal › Article
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
- Contribution to journal › Article
